deborah birx joins us later to discuss. then later. >> we lost an election across the board. so by definition, we've fallen out of touch with the majority of americans. >> can democrats find a way? we'll talk to the chair of the new democrat coalition, congressman brad schneider, about the makeover that they might want for their party. it is 6 a.m. here on the east coast. and look at lady liberty there in new york city this morning, greeting us all on this thursday morning. good morning to you. i'm jessica dean in for kasie hunt. wonderful to have you with us. 18 senate confirmed cabinet members and the vice president all on the guest list for the first cabinet meeting of donald trump's second term, and many of them arriving at that first meeting wednesday at the white house, ready to make some remarks. but when president trump ceded the microphone to someone else in the cabinet room for the first time, it was not to any of them. he deferred instead to elon musk, the world's richest man and senior white house adviser. >> let the cabinet speak just for a second. >> yeah, exact

. >> working alongside former white house coronavirus response coordinator deborah birx as part of u.sital services or usds, the agency that has become doge and that she will now lead a federal worker who has worked with gleason in the past but is not authorized to speak on the record, describing gleason as direct and to the point. super smart. gleason has her roots in health care and tech. a former nurse who says she ran into hurdles navigating the health care system when her own daughter was diagnosed with a rare autoimmune disorder. >> this is. >> one single year of morgan's medical record. >> not having. >> the necessary information causes delays in diagnosis, misdiagnoses, burden on the patient and family, and stress on the doctors and nurses. >> she says that fueled her work to build, implement and streamline electronic medical record technologies. in 2021, gleason joined russell street ventures, a firm founded by brad smith, now also a doge advisor, and then was pulled back into usgs, rejoining the federal government in december. during the transition to the agency that she is,

. >> working alongside former white house coronavirus response coordinator deborah birx as part of u.s. digital services, or usds, the agency that has become doge and that she will now lead a federal worker who. >> has worked with. >> gleason in the past but is not authorized to speak on the record, describing gleason as direct and to the point. super smart. gleason has her roots in healthcare and tech. a former nurse who says she ran into hurdles navigating the health care system when her own daughter was diagnosed with a rare autoimmune disorder. >> this is one single year of morgan's medical record not having the necessary information causes delays in diagnosis, misdiagnoses, burden. >> on the patient and. >> family, and stress on the doctors and nurses. >> she says that. >> fueled her work to build, implement and streamline electronic medical record technologies. in 2021, gleason joined russell street ventures, a firm founded by brad smith, now also a doge advisor, and then was pulled back into usgs, rejoining the federal government in december. during the transition to the agency

but did you see there was an interview that doctor deborah birx, who you worked with during the trumpaid very explicitly that the covid vaccine was, quote, not designed to prevent against infection and effectively said that it was mismarketed by not just the companies but effectively the government. and i'm so curious what your reaction to that is. yeah. >> well, i wasn't in the government at that time. i was in the private sector and pfizer, as you know. so i didn't overlap with debbie. deborah birx, look, when the vaccine was first rolled out, if you remember on this show, we talked about it many times. we were very careful to say that the vaccine, we didn't know if it prevented infection because the original data showed that it prevented severe illness and hospitalization and death in patients. we presumed that if you were reducing infection rates over the over a population, that it would prevent infection. but we didn't know that, and we were very careful to say that. we didn't know that when the data came out from israel showing that dramatically reduced infection across populati